Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Telmisartan + Hydrochlorothiazide
- Therapeutic area
- Cardiovascular
- Drug class
- Angiotensin receptor blockers
- ATC
- C09DA
- Strength
- 40 mg + 12.5 mg
- Dosage form
- Tablet
- Pack
- 2x7's
- Registration no.
- 079772
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-09-27 02:57
Manufacturer
Remington Pharmaceutical Industries (Pvt) Ltd
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
No change in the official DRAP price is recorded for this pack (2x7's). Current price PKR 434.86, effective 1 Jul 2024.
Cite this price history
MedInfoBase. Telzide 40 mg + 12.5 mg, 2x7's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/telzide-40-mg-12-5-mg-079772-2x7s-remington-pharmaceutical-industries-pvt-ltd/ (accessed 27 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 434.86 | 2024-07-01 | 2026-09-22 | DRAP PharmaPrice Index (recovered from snapshot #84) | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 079772Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.
